Kancer LtdKancer Ltd Logo

Kancer will be focussed on the development of new products based upon the reformulation of existing approved therapies and breakthrough treatments for cancer.

Our strategic aim is that:“Kancer will develop unique targetted therapies that can improve the prognosis for patients using our delivery systems and in some cases specifically target a patient's own cancer cells"

Website: www.kancer.co.uk

Key Projects

Kancer’s prospective projects represent a balance of risk and technologies designed to increase the opportunity to make an impact on this disease:

  • Individualised therapy for multiple myeloma
  • Oral GCSF (GMCSF) - white blood cell rebuilder
  • Oral Interferon
  • Inducing Apoptosis - using Special Targetting amino acid construct
  • Possible Cancer Vaccines